StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Quarterly Revenue Recognized from Beginning-of-Year by Quarter

Quarterly Revenue Recognized from Beginning-of-Year Contract Liability Balances (Q1–Q3) ($M)

Thermo Fisher Scientific Quarterly Revenue Recognized from Beginning-of-Year: $710M in Q2 2026, down 2.7% from a year earlier.

Latest, Q2 2026
710
Period ended Jun 30, 2026
Change on a year earlier
-2.7%
730 in Q2 2025
History
22 quarters
Since Q1 2018
Sources
19
Documents cited below

Where the Q2 2026 figure comes from

Source: SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗

The company only discloses absolute quarterly figures for Q1, Q2, and Q3 in 10-Q filings; the full-year 10-K only provides qualitative disclosure: 'Substantially all of the current contract liability balances at year-end was recognized in revenues during the following year'.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedQuarterly Revenue Recognized from Beginning-of-Year Contract Liability Balances (Q1–Q3) ($M)Year on yearSource
Q2 2026Jun 30, 2026710-2.7%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2026Mar 31, 20261,290-5.1%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q3 2025Sep 30, 2025410+13.9%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2025Jun 30, 2025730+9.0%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2025Mar 31, 20251,360+3.0%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q3 2024Sep 30, 2024360+2.9%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2024Jun 30, 2024670-1.5%SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗
Q1 2024Mar 31, 20241,320+1.5%SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗
Q3 2023Sep 30, 2023350+2.9%SEC Form 10-Q (10q_2024Q3, filed 2024-11-01) ↗
Q2 2023Jun 30, 2023680-4.2%SEC Form 10-Q (10q_2024Q2, filed 2024-08-02) ↗
Q1 2023Mar 31, 20231,300+1.6%SEC Form 10-Q (10q_2024Q1, filed 2024-05-03) ↗
Q3 2022Sep 30, 2022340+100.0%SEC Form 10-Q (10q_2023Q3, filed 2023-11-03) ↗
Q2 2022Jun 30, 2022710+91.9%SEC Form 10-Q (10q_2023Q2, filed 2023-08-04) ↗
Q1 2022Mar 31, 20221,280+126.1%SEC Form 10-Q (10q_2023Q1, filed 2023-05-05) ↗
Q3 2021Sep 30, 2021170+19.7%SEC Form 10-Q (10q_2022Q3, filed 2022-11-04) ↗
Q2 2021Jun 30, 2021370+63.7%SEC Form 10-Q (10q_2022Q2, filed 2022-08-05) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Quarterly Revenue Recognized from Beginning-of-Year ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/contract-liab-rev-recognized

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.